A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

January 31, 1993

Primary Completion Date

February 28, 1994

Study Completion Date

February 28, 1994

Conditions
GlaucomaOpen Angle GlaucomaOcular Hypertension
Interventions
DRUG

PhXA41

One drop in the affected eye once daily for six months.

DRUG

timolol

One drop in the affected eye twice daily for six months.

Trial Locations (17)

10003

Pfizer Investigational Site, New York

10029

Pfizer Investigational Site, New York

21209

Pfizer Investigational Site, Baltimore

32610

Pfizer Investigational Site, Gainesville

40292

Pfizer Investigational Site, Louisville

60611

Pfizer Investigational Site, Chicago

60612

Pfizer Investigational Site, Chicago

63110

Pfizer Investigational Site, St Louis

68105

Pfizer Investigational Site, Omaha

90033

Pfizer Investigational Site, Los Angeles

92093-0946

Pfizer Investigational Site, La Jolla

Unknown

Pfizer Investigational Site, Ann Arbor

07661-1931

Pfizer Investigational Site, River Edge

97210-3049

Pfizer Investigational Site, Portland

19107-5599

Pfizer Investigational Site, Philadelphia

29425-0001

Pfizer Investigational Site, Charleston

53705-3611

Pfizer Investigational Site, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY